Cilley R E, Zwischenberger J B, Andrews A F, Bowerman R A, Roloff D W, Bartlett R H
Pediatrics. 1986 Oct;78(4):699-704.
Intracranial hemorrhage is a complication of extracorporeal membrane oxygenation for the treatment of neonatal respiratory failure. A retrospective review of 35 neonates treated with extracorporeal membrane oxygenation was performed; ten had intracranial hemorrhage. Infants with intracranial hemorrhage had lower birth weights and were gestationally younger than infants with intracranial hemorrhage. Eight of eight neonates of less than 35 weeks' gestational age sustained intracranial hemorrhage. Six died immediately after extracorporeal membrane oxygenation was stopped. Two lived less than 1 year. Two of 27 neonates older than 34 weeks' gestational age sustained intracranial hemorrhage. One child is normal, the other died at 18 months of age. Based on the results of this study, the risk of intracranial hemorrhage appears low in neonates of greater than 34 weeks' gestational age who undergo extracorporeal membrane oxygenation treatment for severe respiratory failure. The use of extracorporeal membrane oxygenation, as it is presently performed, is contraindicated in neonates of less than 35 weeks' gestational age because of the risk of intracranial hemorrhage.
颅内出血是体外膜肺氧合治疗新生儿呼吸衰竭的一种并发症。对35例接受体外膜肺氧合治疗的新生儿进行了回顾性研究;其中10例发生了颅内出血。发生颅内出血的婴儿出生体重较低,孕周小于未发生颅内出血的婴儿。孕周小于35周的8例新生儿均发生了颅内出血。8例中有6例在体外膜肺氧合停止后立即死亡。2例存活时间不到1年。孕周大于34周的27例新生儿中有2例发生了颅内出血。1名儿童正常,另1例在18个月龄时死亡。根据本研究结果,对于因严重呼吸衰竭接受体外膜肺氧合治疗的孕周大于34周的新生儿,颅内出血风险似乎较低。由于存在颅内出血风险,目前实施的体外膜肺氧合治疗在孕周小于35周的新生儿中是禁忌的。